A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(10 sites)

United States

Moffitt Cancer Center, Tampa, Florida

Belgium

UZ Leuven, Leuven

Italy

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma

Norway

The Norwegian Radiumhospital, Oslo

Spain

Hospital Universitari de Bellvitge, Barcelona

Clinica Universidad de Navarra, Madrid

Clinica Universidad de Navarra, Pamplona

Hospital Universitari i Politècnic La Fe, Valencia

United Kingdom

Imperial College Healthcare NHS Trust, London

University Hospital Southampton NHS Foundation Trust, Southampton